Oral antidiabetes agents for the management of inpatient hyperglycaemia: so far, yet so close.
Theocharis KoufakisO G MustafaP ZebekakisK KotsaPublished in: Diabetic medicine : a journal of the British Diabetic Association (2020)
The administration of dipeptidyl peptidase-4 inhibitors to specific groups of inpatients might be a safe and effective alternative to insulin.